Literature DB >> 14527706

Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea.

N H Wenk1, N M Nannenga, N C Honda.   

Abstract

In addition to their traditional role in centrally mediated analgesia, opiate compounds produce significant effects when administered peripherally. Using a recently characterized model of acute chemical injury to the rat cornea, we assessed the effects of morphine sulphate eye drops on corneal inflammation and hyperalgesia. Topical application of a 5 microM morphine sulphate eye drop preparation attenuated capsaicin-induced blinking in a concentration-dependent manner. However, morphine had no effect on capsaicin-induced blinking when applied to healthy, non-inflamed rat cornea. In addition, 5 microM morphine given every 2 h following cauterization retarded the development of both stromal edema and the infiltration of immune cells. Both the analgesic and anti-inflammatory effects of morphine were prevented by the opioid receptor antagonists naloxone, CTAP, and naltrindole. We conclude that morphine acts on mu and delta opioid receptors located in the rat cornea to attenuate inflammation and hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527706     DOI: 10.1016/S0304-3959(03)00260-4

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  12 in total

Review 1.  Peripheral opioid analgesia: clinical applications.

Authors:  Jochen Oeltjenbruns; Michael Schäfer
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 2.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

3.  Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.

Authors:  Cicely L Schramm; Christopher N Honda
Journal:  Pain       Date:  2010-12       Impact factor: 6.961

Review 4.  The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Jing Yu; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015-07-15       Impact factor: 2.581

5.  [Topical application of morphine gel in inflammatory mucosal and cutaneous lesions].

Authors:  M Platzer; R Likar; C Stein; E Beubler; R Sittl
Journal:  Schmerz       Date:  2005-08       Impact factor: 1.107

6.  The use of topical nalbuphine in different concentrations to control pain after photorefractive keratectomy.

Authors:  Hala Kamal Mattout; Sameh Mosaad Fouda
Journal:  Int Ophthalmol       Date:  2022-01-12       Impact factor: 2.029

Review 7.  Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye?

Authors:  Jerry P Kalangara; Anat Galor; Roy C Levitt; Elizabeth R Felix; Ramon Alegret; Constantine D Sarantopoulos
Journal:  Pain Med       Date:  2015-12-24       Impact factor: 3.750

8.  Effect of topical administration of tramadol on corneal wound healing in rats.

Authors:  Ozgun Cuvas Apan; Murat Atabey Ozer; Selcuk Takir; Alparslan Apan; Demet Sengul
Journal:  Int Ophthalmol       Date:  2016-01-28       Impact factor: 2.031

9.  The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.

Authors:  Irina Vetter; Bruce D Wyse; Gregory R Monteith; Sarah J Roberts-Thomson; Peter J Cabot
Journal:  Mol Pain       Date:  2006-07-16       Impact factor: 3.395

Review 10.  Association of dry eye disease with psychiatric or neurological disorders in elderly patients.

Authors:  Sang Beom Han; Hee Kyung Yang; Joon Young Hyon; Won Ryang Wee
Journal:  Clin Interv Aging       Date:  2017-05-15       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.